Using progesterone, testosterone, androstenedione, ll-oxoprogesterone and l1~-hydroxyprogesterone as models, a new form of isotope dilution assay has been developed. A known mass of deuterium-labelled steroid is added to the serum sample. High-performance liquid chromatography is used to separate endogenous steroid from its deuterium-labelled form. After separation, the two forms of the analyte are quantitated using conventional methods: radioimmunoassay, enzymelinked immunoassay and, where the concentrations are high enough, ultraviolet light absorption. The ratio of the amounts of the two forms of the analyte is used to calculate the amount of unlabelled material in the original sample.
In the clinical laboratory a large number of substances are assayed after purification by chromatography. Phenolic metabolites are often assayed by amperometry after high-performance liquid chromatography (HPLC).1. 2 Plasma and urine cortisol can be assayed by spectrometry after HPLC. 3. 4 Many drugs in blood, saliva or urine are assayed by ultraviolet (UV) spectrometry after liquid chromatography." Often, as in the case of amino acids, derivatives are made in order to improve detection sensitivity. (, High-resolution gas-liquid chromatography is often used to afford the required separation. Quantitation is by electron capture, flame ionisation or nitrogen-sulphur detection." H In all of these methods, recourse is made to the use of an internal standard to correct for procedural losses. The internal standard is a compound which, it is hoped, never occurs in the sample yet is chemically closely related to the substance to be measured. The internal standard mayor may not behave similarly to the analyte under all conditions.?: 10 Under some conditions, extraction efficiency or chemical reactivity with reagents or with the chromatography column may differ from the analyte. The response of the detector toward the two compounds may vary. The use of a different chemical compound as an internal standard may give satisfactory results under carefully controlled conditions, for example during the development of a method. Undetected errors may occur under less well controlled conditions.
A fundamental limitation to the use of a different compound as an internal standard is that it is only suitable in combination with a non-specific detection method such as UV light absorption. The use of specific 'detectors' such as immunoassay reduces the number of suitable internal standards drastically; perhaps even to one, the analyte itself.
Generally, the most reliable approach to complex analytical procedures requiring the use of an internal standard is to use 14C_ or 3H-labelled analyte to monitor analytical losses.
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Pratt This approach is always adopted for immunoassays for steroids!': 12 and prostaglandins. 13 Basically, the same approach is used in gas chromatography-mass spectrometry (GC-MS) where the analyte, labelled with a stable isotope, usually deuterium, is used as the internal standard. The use of isotopically-labelled internal standard is largely responsible for the generally high accuracy of these methods which has led to GC-MS methods being proposed as 'reference methods' for several analytes important in clinical chemistry. 14--18 This paper outlines a new approach to isotope dilution methods of analysis. A known mass of isotopically-labelled analyte is added to the sample. Using chromatographic methods with very high resolution, it is possible to separate physically the endogenous analyte from its labelled analogue. Using the same detection system, both forms of the analyte are quantitated. The ratio of unlabelled analyte to labelled analyte found after chromatography is assumed equal to the ratio before purification. The procedure is illustrated in Fig. 1 . The original concentration of the unlabelled analyte in the original sample can be calculated easily.
It is, of course, not necessary to refer the responses back to a standard curve, although in two of the examples treated in the following text, using radioimmunoassay (RIA) and enzyme-linked immunoassay (EIA) as 'detectors', this is in fact done. In other examples to follow (RIA and UV absorption), only linear response-parameters are used to determine the ratios and give accurate results. In other systems, other detectors giving a linear response, e.g. electron-capture current, fluorescence or amperometric response could be used.
It is not necessary that the labelled preparation be chemically pure as long as a quantitative estimate of the purity is included in the calculations. If the chromatographic efficiency is high enough or if the 'detector' is specific enough, impurities will not interfere. Under these conditions, the chemical purity of the preparation can be determined by adding an accurately known amout of the pure, unlabelled substance to the chemically impure, labelled preparation and subjecting the mixture to chromatographic separation. The chemical purity can be calculated from the measured isotope ratio. This is a form of reverse isotope dilution. Most of the results of the progesterone isotopedilution assay were obtained using Dyprogesterone containing 6% Dy-iso (l7a)progesterone. The latter was detected by ultraviolet light absorption but not by the immunoassays used for serum samples. In this paper, D is used as the chemical symbol for deuterium CZH) and T for tritium CH).
The labelled product need not be isotopically pure. The effect of isotopic heterogeneity is to lower and broaden the peak attributable to the labelled analogue. All of the deuteriumlabelled preparations used in this study showed such a broadening compared with the isotopically homogeneous, unlabelled material which was, co-injected. The heterogeneity was con- FlG. 1. The principle of the isotope dilution assay proposed in this article. The values in the valley between the two peaks are discarded. a and b are the areas of the peaks attributable to the unlabelled substance and the labelled substance respectively. B is the amount (or concentration) of labelled substance added to the sample. A is the amount (or concentration) of unlabelled substance which is to be measured. firmed by mass spectrometry. Despite the lowering and broadening. the peak areas agreed with expectations.
In contrast with GC-MS assays. partial exchange of deuterium for protium from the solvent during the assay will not affect the results provided that the extent of exchange is moderate. As shown in Fig. 2 . the effect of partial exchange is to broaden the peak attributable to the analogue and to change its mobility slightly. The occurrence of an unacceptable degree of exchange during the assay will always be evident on inspection of the results.
Isotope efTec:ts in chromatography
Isotope effects in the chromatography of compounds with high molecular weight have been 
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the subject of study for at least 36 years. A survey of the literature reveals that this phenomenon received more attention in the years 1950-1968 than in the years since. The reader is refered to the 1966 review by Klein l '! which is still the most useful source of information in this area. In these earlier years. there was a reluctance to take chromatographic isotope effects seriously. The suspicion was always that the effects reported in poorly documented publications could be explained by faulty technique or the presence of radiochemical impurity. This suspicion was often justified; the history of the use of isotopic tracers is rich in artefacts of this kind. The most valuable contribution of Klein's review was to convince the scientific community of the reality and magnitude of these effects. He stressed the necessity of adequate experimental documentation in this field. In the present publication. considerable attention has been paid to formal demonstration of the chemical identity of the deuteriumlabelled tracers used.
Isotope effects are observed in all forms of chromatography. Lauragh, Sealey and Klein. using a paper chromatography system with very low resolution (about 250 theoretical plates) demonstrated a shift in the isotope ratio when tritium-and carbon-14-labelled aldosterone diacetate were co-chromatographed. 211 Recalculation of their data for a hypothetical paper-chromatographic system with 20 O(X) theoretical plates (typical of a good HPLesystem) shows an almost base-line separation. This conforms with the magnitude of the effects reported in this publication.
In this laboratory. we have frequently observed large shifts in isotope-ratios when 14eand T-Iabelled steroids are co-chromatographed on thin-layer chromatography (TLC). The isotope effect due to the presence of a single 7«tritium atom is easily measurable.
Marshall and Magee showed a substantial shift in isotope ratios when (I.1 4 -Q -lyxose was co-chromatographed with p.l2C)-lyxose in a low resolution counter-current system."
Bentley. Saha and Sweeley demonstrated an almost baseline separation of l\-glucose and its Ds-analogue when these were co-chromatographed as their pentakis-trimethylsilyl ethers in a high resolution GLC system 22 Substantial shifts in isotope ratios. but nothing like complete separation. were noted in various partition chromatographic systems. 2.\ 25 Using modern HPLe. almost complete separation of normal palmitic acid. C I5H'ICOOH. from QJ :g 8 3: per-deutero-palmitic acid, C I 5D31COOH, was reported." Partial separation of deuterated drugs from the corres~onding unlabelled materials was observed. 7, 28 All of these observations were reported only as laboratory curiosities or as potential sources of error in subsequent GC-MS.
More recently, the separation of per-deuterobenzene (C 6D 6 ) and the partial separation of per-deutero-diazeparn (C I5H2D\\Cl N 20) from the unlabelled forms were used as criteria of chromatographic performance.j": 31J The partial separation of tritium-labelled methyl chlorpromazine from the unlabelled material was reported." The use of this method to improve the specific activity of some tritium-labelled compounds was suggested, Per-deuteroethylene dibromide has been used recently as an internal standard in the gas-liquid chromatographic analysis of unlabelled ethylene dibromide.F During the last 6 years, this laboratory has devoted considerable effort to optimise the conditions for the HPLC-separation of isotopically-labelled compounds from their unlabelled forms. Early experiments were performed using conventional HPLC columns. Examples are shown in Figs 3 and 4. Early experiments showed that the separation factor per substituted deuterium atom was approximately half that for tritium so that separations had to be improved considerably if the phenomenon was to be of any use.
Separations on reversed-phase columns (at similar retentions and calculated 'platenumbers') were influenced markedly by the solvent composition. The best separations by 6 10 ũ .,
x r x \ r : and unlabelled prostaglandin-E, (____..). The radioactive species were assayed on aliquots of each 'fraction by liquid scintillation spectrometry. The unlabelled prostaglandin was measured by radioimmunoassay on dilutions of the chromatographic fractions. The mass of unlabelled prostaglandin in the injected mixture (about 5 ILg) was far greater than the mass attributable to the 14C-labelled prostaglandin (about 150 ng). The broadening of the tritium-peak compared to the other two is probably due to isotopic heterogeneity. This is made more likely by the fact that the specific activity (170 000 Cilmol) falls far short of the theoretical maximum. The column was a 12x 1·2 em 'RCM', 5 ILm, 'C 1 . ' column of Waters Co. The eluant was a mixture of acetonitrile, water, benzene and acetic acid. reversed-phase were only about half those obtained using silica gel adsorption. Isotope separation by adsorption chromatography was apparently independent of solvent composition (at constant retention). Thus, hexaneacetonitrile mixtures gave separations similar to dichlormethane-iso-propanol mixtures. As is to be expected for the separation of substances of very similar chromatographic mobilities, isocratic elution gave much better results than gradient elution.
The most important factor affecting isotopic separation is overall retention time. For adsorption chromatography, separation was marked only when the relative retention exceeded about 6. The relative retention is the ratio of the elution time of the analyte to the 'elution time' of the injected solvent. For analytical separations, relative retentions exceeding 15 were often used. At such long retention times, the separated components are diluted in a comparatively large volume by the time they elute. Striving to improve 'efficiency' by reducing 'dead volume' below a reasonably attainable level serves no purpose. Reducing the particle size of the adsorbant from 10 urn to 3 urn resulted in only marginal improvement.
When chromatographic efficiency cannot reasonably be improved further, the usefulness of this form of isotope dilution can be extended by incorporating more isotope atoms per molecule. There is, however, a limit to this. In studies not reported in detail in this paper, the isotope effect given by 2, 2, 4, 6, 6, 16, 16-Drandrostenedione (prepared by acidcatalysed exchange as described in this paper) was compared with that of D 11 -12androstenedione. The latter was prepared in low yield by heating androstenedione with DzO, acetone-D; and per-deutero benzoic acid with platinum oxide in a sealed glass vial at 180 0 for three days. Under these conditions, the 2, 4, 6 and 16-positions will be substituted. The positions of the remaining five deuterons are unknown. The mass spectrum was unhelpful because the material was isotopically grossly heterogeneous. The product showed a chromatographic mobility that hardly differed from that of the De-preparation. It is therefore probable that the position of substitution is important and that deuterons near the polar groups of the steroid have the greatest effect on chromatographic mobility.
The C-D bond is more polar than the C-H bond.j": 33 This is reflected in the relative mobilities. Deuterium-substituted compounds always migrated faster in reversed-phase systems and slower in adsorption chromatography.
The analytical approach outlined in this paper became practicable only when several microbore columns were coupled in series. Separations of some deuterium-labelled analogues from the labelled steroids obtained in this laboratory using microbore columns (total length, 125 ern) are shown in Fig. 5 . Using conventional apparatus and n-pentane-based solvents, it is possible to use up to 16 commercially-available microbore columns in series. Table 1 summarises the characteristics of very high resolution chromatography systems currently available or under development. These data are partly based on work performed in this laboratory and partly on a review of the extensive literature on this subject. The estimated numbers of theoretical plates are based on the so-called 'tangent method' of calculation. A recent publication explains this and other methods and makes it clear that the estimate is highly dependent on the method of calculation.P'
Materials and methods
All reagents, including solvents for chromatography, were of analytical grade and were obtained from Merck Co., Darmstadt, Germany. All non-labelled steroids were obtained from Steraloids Co., Wilton, NH, USA. The purity of each steroid was checked by TLC and its identity confirmed by melting point determination and mass spectrometry. Radioactive steroids were obtained either from NEN Co., Dreieich, Germany or from Amersham International, Bucks., UK. Their identities were checked by TLC and by their ability to bind to specific antibodies. They were re-purified by HPLC shortly before use.
Coventional HPLC columns were obtained either from Waters Co., Milford, Mass., USA (Radial Compression System) or from Serva Co., Heidelberg, Germany (stainless steel columns, 0·42 ern diameter, various lengths). Microbore columns (25xO·1 ern; stainless steel; silica, type: 'partisil-lO') were obtained from Whatman Co., Clifton, NJ, USA.
A Waters solvent pump (type: M-6000-A) was used for both conventional HPLC and microbore HPLC. In the latter case, optimum flow (nominally 55 ul, per min, in fact 48!-tL per min) was achieved with the use of the 'Microflow Module' of Waters Co. A Jasco 10 ul, sample injector was used. In each case, about 50 ng of each isotopic species was injected onto the columns. The separations were performed using five microbore columns in series. Chromatographic conditions were otherwise similar to those summarised in Table 2 . Elution is, in each case, from right to left. The ordinate is ultraviolet light absorption. The upper panel concerns progesterone. PII. PI z, PI, and PI. are the times at which mixtures of protium-and deuteriumprogesterone were injected. PF" PF z, PF, and PF. are the signals due to the injected solvent ('solvent fronts'). Plo P z, P 3 and P, are the eluted pairs of isotopic forms of progesterone. In each case, the H-progesterone:Dprogesterone ratios were calculated by manual integration. These values are found underneath each pair of peaks. Underneath these. in brackets, you see the real ratios (on a molar basis) of the weighed isotopic forms in the injected mixture. In the second panel you see the corresponding elution curves for five testosterone mixtures. The last pair of testosterone peaks is omitted. The lower panel shows the elution diagram of a single sample containing protium and deuterium forms of both ll-ketoprogesterone and l lji-hydroxyprogestcronc.
For experiments on pure labelled and unlabelled steroids, absorption at 254 nm was measured using a Waters model 440 spectrophotometric detector. For isotope dilution assays of plasma testosterone using UV absorption at 248 nm, a model LC-95 variable wavelength detector from Perkin-Elmer Co.
(Norwalk, CT, USA) was used. Both' detectors were fitted with 0·5 ul, flow cells. Detector 'noise' in operation was ±O·OOO 2 and ±O·OOO 02 absorption units respectively. The detection limits for steroidal L\-4,3-ones using the two detectors were 3 ng and 0·3 ng respectively when very long retention times were used. Mass spectra using electron impact ionisation were obtained using a Finnigan MAT-212 mass spectrometer equipped with a SS-200 data system.
Melting points were obtained using a paraffin heating bath. Several melting point tubes could be placed very close together and the melting points of their contents determined simultaneously. In this way, very accurate comparisons could be made.
SYNTHESIS OF DEUTERIUM-LA 8ELLED

STEROIDS
Synthesis of deuterium-labelled steroids was by acid-catalysed exchange and sodium borodeuteride reduction. These methods incorporate large numbers of deuterons into positions which maximise the chromatographic isotope effect per deuteron (see the section on isotope effects in chromatography above). The exchange reaction for progesterone is shown in Fig. 6 .
The deuterium atoms introduced by acidcatalysed exchange might be assumed to be particularly sensitive to back-exchange later in the assays. Although this probably occurs to a slight extent, no evidence for this could be found. In the case of ll-ketoprogesterone, exchange under assay conditions (neutral aqueous solution in the absence of silica gel and on silica gel chromatography in the absence of water) was actively sought but not found. However, it is likely that back-exchange of one deuteron in the A-or B-ring of testosterone occured during its synthesis which included TLC on silica gel with dichlormethanemethanol as solvent. The TLC plates were not anhydrous. We have strong evidence that hydrous silica gel exchanges protons with steroidal ketones (Chapman, Kraan and Pratt, in preparation).
The deuterium atoms incorporated by the above reactions occupy positions similar to tritium in commercially available radioactive steroids. Although the latter are not immune to exchange, they can, with experience, be used without these problems. The extensive data on the stability of T-steroids 35 can be used for the D-analogues described in this paper. The deuterium-labelled steroids described in this publication were stable for months or years when stored in neutral anhydrous ethanol or iso-propanol in glass containers in the dark at 4°.
Progesterone-Des
Water and possible alcohol of crystallisation were removed as azeotropes by dissolving 100 mgofthe steroid (0·318 mrnol , 2·82 mAtom exchangeable protons) in 10 ml of anhydrous acetone-benzene (1:1) and evaporating to dryness. The residue was dissolved in 2 ml tetrahydrofuran (C 4HsO). 1 mL of 20% DCl in D 2 0 was added. The solution containing about 110 mAtoms of exchangeable deuterons was kept in the dark for 4 days at room temperature. The mixture was extracted repeatedly with small volumes of n-pentane until no more solid was recovered. An equal volume of benzene was added to the extracts and the mixture evaporated to dryness. TLC (silica gel, dichlormethane-methanol (99:1)) showed a major component with the same mobility as progesterone and a minor component which was 17u-progesterone, the expected product of the action of strong acid on 1713-progesterone. The product was repeatedly re-crystallised from methanol. The purity of the product was monitored by TLC. After the fifth crystallisation, the progesterone was substantially pure (less than 0·5% iso-progesterone). In some experiments, a crude preparation was recovered after only one crystallisation. This product proved to contain 6% iso-progesterone (determined by reversed-isotope dilution, see the Introductory section above) but was nevertheless useable for isotope dilution assays. The product was dissolved in anhydrous acetone-benzene (1: 1) and evaporated to dryness to remove possible methanol of crystallisation.
Androstenedione-Dg., 100 mg of water-free and alcohol-free androstenedione (0·35 mmol, 2·45 mAtom of exchangeable protons) was dissolved in 2 mL of acetone (C 3D6 0 ) . 1 mL of 20% DC! in D 2 0 was added. The solutions containing about 270 mAtom of exchangeable deuterons was kept in the dark at room temperature for 10 days. Extraction was as for progesterone. Two crystallisations from methanol served to give a homogeneous product with the same mobility as authentic androstenedione on TLC (silica gel, dichlormethane-methanol (98' 5:1·5)). Possible methanol of crystallisation was removed as above.
Testosterone-De» Androstenedione-De-was reduced with sodium borodeuteride. The yield of the 17hydroxy compound (as opposed to 3-hydroxy compounds) was optimised by performing the reduction of 19% water in ethanol as solvent. Unfortunately, deuterium atoms in the reduc-tant exchange quite rapidly under these conditions necessitating the use of deute rated solvents. Acidification during the work-up must be avoided otherwise the double bond will be reduced. 10 mg of androstenedione-De, (34,8 umol) was dissolved in 2 mL of ethanol (C 2HsOD). 0·56 mg of NaBD 4 (13·3 urnol) in 0·2 mL D 2 0 was added. The solution was allowed to stand at 6°for 20 h. 0·2 mL of acetone (C 3D6 0 ) was added and the reaction allowed to continue for 2 h at room temperature. 2 mL of water (H 2 0 ) was added and the mixture was extracted with 10 ml of dichlormethane. 10 mL of benzene was added and the whole evaporated to dryness. The crude product was purified by TLC [silica gel, 0·25 mm thick, dichlormethane-methanol (95:5)]. The testosterone was well separated from 3-hydroxy-impurities. The product was eluted from the silica powder with dichlormethane-methanol (95:5). It was re-crystallised from acetone-iso-octane to remove traces of 17u-testosterone.
Mass spectrometry showed that the product contained the same number of deuterium atoms as the androstenedione starting material indicating partial exchange during the purification (see above). Incorporation of deuterium into the 17u-position was confirmed in a control synthesis using androstenedione (C,'}H 26 0 2 ) and NaBD 4 .
ll-Oxoprogesterone-D10_11
Exchange-in of deuterium was performed as for progesterone. The product was extracted from the reaction mixture with benzene and recrystallised several times from methanol to remove an impurity (probably 11-keto-17uprogesterone). Mass spectrometry showed extreme isotopic heterogeneity with a preponderance of D'}, Dill and D11-species ( Fig. 7 ). This is probably due largely to the very slow exchange of C-12u protons." Part of the product was enriched by preparative HPLC [silica gel, column dimensions:25x 1·2 em, eluent: nhexane :iso-propanol (96:4)]. 11-Ketoprogesterone was eluted after 1 h. Samples were injected every 8 min. The first 60-80% of each of the train of peaks was discarded. The remaining part of each peak was collected and pooled. Mass spectrometry on the product showed reduced isotopic heterogeneity with Dwspecies predominating and with a greatly reduced percentage of D'}-and Ds-species. The product gave a sharper peak in analytical HPLC when used for isotope dilution assays. This . The general features of the two spectra are similar. The large number of low molecular weight fragments from the labelled preparation is due to isotopic heterogeneity. The unlabelled steroid gives a molecular ion at relative mass (RM) of 328. The labelled steroid, which had not been subjected to 'chromatographic enrichment' as explained in the text, showed two molecular ions at RM=339 and 338. Species with molecular ions at RM=337 are also prominent.
illustrates the preparative applications of chromatographic separation of isotopic forms of the same compound.
11fJ-Hydroxyprogesterone-D/j-9 Exchange-in of deuterium atoms was performed in the same way as for progesterone.
The product was extracted with benzene. An equal volume of methanol (CH 4 0 ) was added and the whole evaporated to dryness. The methanol served to remove easily exchangeable deuterons. The product was re-dissolved in benzene and evaporated to dryness in order to remove possible alcohol of crystallisation. The solid was re-crystallised three times from acetone-iso-octane.
REFERENCE RADIOIMMUNOASSAYS
Serum progesterone was assayed using the antisera raised against protein conjugates of progesterone-7a-(carboxyethyl)thioether described below. Plasma samples were extracted with n-pentane. Extraction efficiencies were calculated for each sample using small quantities of tritiated progesterone. Only 5a-pregnan-3, 20-dione is known to interfere in the assay (10% cross-reaction). This assay has been subjected to the usual tests of analytical accuracy.37-39 The results agree with concensus values of several external quality control schemes and with GC-MS determinations. Androstenedione was determined using the antisera to protein conjugates of androstenedione-7a-(carboxyethyl)thioeter described later. The details are the same as for progesterone.
Plasma testosterone was assayed as previously described.t" In addition to the formal tests of accuracy described in this publication, the results agreed consistently with concensus values in several external quality control schemes and with GC-MS assays.
In the cases of androstenedione and testosterone above, the imprecision of the 'reference immunoassay' was very low because concentrations in the optimum ranges of the precision profile were chosen, and means of duplicates were used. The average imprecision was ±5·2% (~D)-:-v'2=±3·7% (SB). The imprecision of the HPLC-isotope dilution-radioimmunoassays was similar because each peak (H or D) is made up of five duplicate radioimmunoassay determinations. The imprecision of the progesterone assays was greater because of the adaptation of the assay to a far greater dynamic range (0'5-60 nM) necessary for this hormone and the greater concentration range actually used in this study.
ISOTOPE DILUTION ASSAYS USING HPLC
Sample extraction
Progesterone. A known amount of DK.-Y progesterone (about 8 ng per sample) in 0·1 mL of 10% glycerol in iso-propanol was evaporated and mixed with the plasma. Between 0·5 and 4·0 mL of plasma was used per assay. The mixture was allowed to equilibrate for 1 h at room temperature. The mixture was extracted with 20 mL of n-pentane and the extract evaporated to dryness. The extract was dissolved in 30 ul, of dichlormethane-iso-octane (10:90) and a 10 ul, aliquot injected onto the micro bore columns.
Androstenedione. Extraction was performed in the same way as for progesterone. About 7 ng of D6-Tandrostenedione was used per sample.
Testosterone. A known amount of D6-T testosterone (about 7·5 ng per sample), about 20 Ilg of cortisol per mL of plasma and about 10 ug of oestradiol per mL of plasma were added to 0·1 mL of 10% glycerol in iso-propanol. The mixture was evaporated. Between 0·5 and 3·5 mL of plasma was added, mixed and allowed to equilibrate at room temperature for 1 h. Extraction and injection onto the microbore columns was the same as for progesterone.
Oestradiol and cortisol displaced testosterone from sex-hormone-binding globulin and cortisolbinding globulin. This permitted the use of n-pentane as extractant. In the absence of oestradiol and cortisol, polar solvents had to be used which increases the risk of fouling the chromatography columns.
11-Ketoprogesterone and 11~-hydroxyproges terone. Extraction and sample injection were the same as for testosterone except that 10 or 25 ng of each deuterated steroid per sample were used and that 20% dichlormethane in n-pentane was used as extractant.
Chromatography
For the isotope dilution assays for progesterone, testosterone, ll-ketoprogesterone and 1l~ hydroxyprogesterone, four microbore columns were connected in series. For the more difficult separation of androstenedione from androstenedione-Dg,», a fifth microbore column was added. Because of the long elution times, it was necessary to be able to predict the fractions to be analysed. Without precautions, the elution times were erratic. A solvent-conditioning HPLC column (3 lim silica, 12·5xo-42 ern) was incorporated between the pump and the injector, resulting in a great improvement. The erratic behaviour was almost certainly due to traces of water in the solvents. Removal of water using the conditioning column may well have improved the results by eliminating isotopic exchange catalysed by the silica gel (see above).
In order to be able to flush and equilibrate the comparatively large pre-injector volume (pump volume plus pulse-suppressor plus conditioning column=ca. 5 mL) in a reasonable time, a three-way-tap was fitted immediately before the injector. The pre-injector volume was flushed for at least 1 h at 800 IiL per min (3 h if a new batch of solvent was used). The flow was reduced to 48 IiL per min and the tap switched to connect the microbore columns. These columns were equilibrated for at least 1 h before the injection of the first sample (3 h if a new batch of solvent was used). Using solvents based on iso-octane, the back-pressure was between 1500 and 2500 pounds per square inch.
A purely pragmatic method was used for determining the optimum pump speed. A roughly equimolar mixture of the labelled and unlabelled steroid was injected. Using ultraviolet absorption, the ratio of the peak-height of the protium peak to the inter-peak trough was determined at various pump speeds and the optimum selected. This approach avoids difficulties posed by asymetric peaks in the calculation of 'plate-numbers' and therefore of separation factors.
The solvents and elution characteristics for the model compounds used in this study are shown in Table 2 .
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Radioimmunoassay following isotope separation A bovine serum albumin conjugate with progesterone-Zc-fcarboxyethyl)thioether was prepared according to Bauminger, Lindner and Weinstein.v' Conjugates of androstenedione-7a(carboxyethyl)thioether and testosterone-7a-carboxyethyl)thioether with bovine serum albumin were prepared according to Weinstein et al. 42 A bovine serum albumin conjugate of 11a-hydroxyprogesterone-11-hemisuccinate was prepared according to Kohen, Bauminger and Lindner.P These conjugates were mixed with Freund's complete adjuvant and used to immunise rabbits. Antisera were harvested after at least 6-monthly injections. Antisera to the 7a-conjugates of progesterone, androstenedione and testosterone were selected on the basis of low cross-reactions with similar, physiologically important steroids. Antisera against the progesterone-lla-conjugate were selected on the basis of high cross-reactions with ll-oxoprogesterone and ll~-hydroxy progesterone and low cross-reactions with other physiologically important steroids such as 17a-hydroxyprogesterone, 5a-pregnan-3,2odione and Su-pregnan-Lztl-dione-Lljl-ol. Dissociation kinetics indicated that the antisera have equilibrium constants in the range 10-11 _ 10-13 M.
In the case of progesterone, androstenedione and testosterone, chromatography fractions were diluted with isopropanol containing 0·1 % glycerol. Portions were mixed with about 30 fmol of 3H-steroid, evaporated and incubated with diluted antiserum. Incubation was for 1 h at 37°followed by 20 h at 2°. Free and antibody-bound radioactivity were separated with active charcoal.
In the case of ll-oxoprogesterone and ll~- 89·2  10·0  0·8  20  210  20000  Androstenedione  89·0  10·0  1·0  25  270  29000  Testosterone  87·8  10·0  2·2  20  180  19000  11-ketoprogesterone  86·2  10·0  3·8  20  130  18000  11f3-hydroxyprogesterone  86·2  10·0  3·8  20  260  16000 hydroxyprogesterone, the cross-reactions (and therefore the assay sensitivities) were increased by using the 'sequential saturation' method. 44 Chromatographic fractions were evaporated and incubated with antiserum dilution (1 h at 37 0 followed by 20 h at 00). Tritium labelled progesterone in the special assay buffer (see below) was then added to each assay tube and mixed well. The incubation was continued for 30 min at 00. Separation of antibody-bound and free steroid was with active charcoal suspension. The increase in sensitivity and of crossreaction obtained by using the 'sequential saturation' method is dependent on a reasonably long dissociation half-life time of the steroid (or cross-reacting steroid) to be measured. If the dissociation half-life time is short (in the order of a few minutes), re-equilibration with tritium-labelled steroid will occur during the second 3D-min incubation. This will result in the same low sensitivities as are found in equilibrium immunoassays for cross-reacting antigens. Experiments performed in this laboratory indicate that the dissociation rate constants of steroid-antibody complexes are markedly decreased in the presence of ammonium sulphate. The presence of up to 1·0 M ammonium sulphate can increase the sensitivity of sequential-addition assays markedly (1 1 Pratt et al., in preparation). The incubation buffer used for the assays of ll-ketoprogesterone and ll~ hydroxyprogesterone was as follows: sodium phosphate 0·1 M, pH 6·60; ammonium sulphate, 0·25 M; bovine y-globulin, 1 mg per mL.
'Non-specific binding' is not constant but is proportional to the amount of non-antibodybound radioactivity. Each estimate of radioactivity was corrected taking this into account. 40, 45 The reciprocal of the corrected values was plotted against the concentrations of the standards. The result is effectively a straight line. 45 Examples of such straight lines are given in the Results section. When such standard lines are used, the non-parametric linear regression method of Theil was employed.46-4M This method has also been used in enzymekinetics and other physiological studies. 49-52 For many purposes, this non-parametric regression calculation gives estimates that are demonstrably more accurate than the usual least-squares methods (Pratt, Bosman and Hindricks, in preparation).
Enzyme immunoassay following isotope separation
Reagents for the enzyme-linked immunoassay of progesterone were obtained from the Instituut voor Veeteeldkundig Onderzoek-Schoonoord, Zeist, The Netherlands, by courtesy of Dr D van de Wiel. Antibodies to progesterone-7a-(carboxyethyl)thioether are adsorbed onto the wells of microtiter plates. The labelled antigen was a conjugate of progesterone with horseradish peroxidase. Antibody-bound enzyme was measured using hydrogen peroxide and tetramethyl benzidine. After incubation, the reaction was stopped with dilute sulphuric acid and the absorption of light at 410 nm measured.
Calculation of the isotope ratio
Only in exceptional cases was the separation of a steroid and its deuterium-analogue complete in the sense that a base-line response was reached between the peaks. As shown in Figs 5 and 10, a small overlap is usually found. Many mathematical methods are available for the quantitation of partially-resolved peaks. 53-55 Some of these methods have been proposed for use when one component produces only a 'shoulder' on the peak of the second component so that they would certainly give accurate results even when the separations are considerably worse than those considered in this publication.
A simpler, provisional approach was used in this study. The trough between the two peaks was located and a narrow increment either side of this point was drawn. The areas or quantities within this section were discarded and the remainder was used to calculate the isotoperatio as shown in Fig. 1 . Superimposing the peaks found for the protium-and deuteriumforms injected separately indicated that approximately equal fractions of both peaks were rejected by this procedure.
At the optimum pump speed, peak asymetry was not pronounced. Tailing of the protium peak limited the accuracy of the method when the HID-ratio was unexpectedly high. For the most accurate results over the widest concentration range, fairly large amounts of the deuterium-labelled analogue should be used as the internal standard. The final results were independent of the amount of deuterium tracer used within a wide range. The accuracy and precision of the results deteriorated, however, when HID-ratios above about 4 were found. At HID-ratios below 0·1, the accuracy and precision again deteriorated. More accurate methods of calculating the isotope-ratios, improved chromatographic separation and sys-tematic attempts at using the optimum of the immunoassay precision-profile would all improve the dynamic range further.
Results
CRITERIA OF CHEMICAL IDENTITY OF THE
LABELLED SUBSTANCES
Because of the reservations concerning chromatographic isotope effects expressed by earlier workers (see the section on Isotope effects in chromatography above), special effort has been made to provide convincing evidence concerning the chemical identity of the labelled substances used. Isotope substitution produces small changes in chromatographic mobility and might produce measurable changes in other physical properties. If this were the case, formal proof that the two substances, the authentic analyte and the putative deuterium-labelled analogue, are forms of the same chemical compound would not be as simple as appears at first glance. It is not wise to attach too much weight to highly accurate measurements of one physical property. It is better to select as many independent criteria of chemical identity as possible and to seek no more than reasonable agreement for each criterion. The following determinations were performed on each of the putative deuterium-labelled compounds used in this study.
Mass spectrometry
The mass spectra of the putative deuteriumlabelled compounds showed the same major features as the authentic, unlabelled compounds. Because the deuterium-labelled compounds were to a limited extent isotopically heterogeneous, their mass spectra showed a super-abundance of minor, low-mass fragments. Fig. 7 shows the mass spectra of ll-oxoprogesterone and its putative deuteriumlabelled analogue.
Control experiments with protium-exchange
The syntheses were repeated using exchangeable H instead of D. Mixtures of the purified products with authentic, unlabelled steroid showed only a single peak in the above HPLC systems without a trace of peak-broadening.
Reaction with specific antibodies
Standard curves in a radioimmunoassay using deuterium-substituted product or untreated steroid were undistinguishable. The errors in the gradients estimated from the dispersion Isotope dilution analysis 263 of the experimental points and systematic weighing and dilution errors varied between 2% and 5% in various experiments. The standard lines for progesterone and its putative D~9-analogue are shown in Fig. 8 .
In a recent publication, exceedingly large isotope effects were reported for the binding of testosterone to antibodies.P" Using 50 different antiserum preparations raised against eight different steroid hormones in about 30 rabbits and two of the anti-testosterone serum preparations used by Xing and Cekan, we have been unable to confirm these findings. In all cases tested, association and dissociation rate constants were independent of the degree of tritium-substitution. Where tested, standard curves using deuterium-substituted steroids were indistinguishable from those using unsubstituted steroid. Scat chard plots were predict- able on the basis of the experimentallydetermined specific activities and zero isotope effect. I believe that the results of these authors can be explained on the basis of the use of incorrect specific activities and of partial exchange of tritium with solvent during 'purification', storage or the experiment itself. The results of experiments in our laboratory will be published shortly.
Formation of chemical derivatives
Authentic steroid, the putative deuteriumanalogue, and various mixtures of the two were added to a solution of (O-methyl) hydroxylamine in pyridine (1 mg/mL). The steroid concentration was 1 mg per mL. The solvent was chosen because methoxime-formation in pyridine shows only a slight degree of selectivity for A-4, 3-ketones compared with other solvents. The solutions were allowed to stand at room temperature for exactly 10 min. The reaction was quenched by adding 1 mL of the reaction mixture to 100 mL of 1 M HCl in water. The acidified mixture was rapidly extracted with benzene and evaporated to dryness. The products were chromatographed on silica gel HPLC systems where the relative retention time of the unreacted steroid (the most polar component) was about 2. Under these conditions, chromatographic isotope effects are hardly noticeable on the UV-absorption trace. The mixtures were also analysed on the HPLC systems described in Table 2 where the unreacted steroids eluted with relative retentions of about 12 and where pronounced isotope effects are to be expected. Detection was by UV-absorption at 254 nm. The reaction conditions were chosen so that methoxime formation was only partial. Progesterone, for example, gave a spectrum containing nine products, all present in different concentrations: unreacted progesterone, the two 3-mono-(O-methyl)oximes (syn-plus anti-), the two 20-mono-(O-methyl)oximes (syn-plus anti-) and the di-(O-methyl)oximes (4 syn-antiisomers).
When the relative retention times were low, the chromatographic spectra given by the putative deuterium-labelled analogues were identical with the spectra given by the untreated steroids, and by mixtures of the two. When the relative retention times were high, chromatographic spectra given by the putative deuteriumanalogues were similar to those given by the authentic steroids. Mixtures gave double peaks attributable to chromatographic isotope effects.
The ratios of the peak areas of the double peaks were close to those predicted on the basis of the various compositions of the original mixtures. Small discrepancies in peak areas can be ascribed to chemical isotope effects in the formation of the methoximes.
The spectra of reaction products are very information-rich. Not only must nine reaction products be recovered for each putative deuterium-labelled diketone, but each product must have a similar chromatographic mobility and extinction coefficient and be formed with a similar rate constant compared with authentic, unlabelled steroid.
Ultraviolet spectra
The UV absorption spectrum (A. ma x and molar extinction coefficient) of each putative deuterium-labelled analogue was identical with that of the authentic steroid.
Crystal form
When crystallised under similar conditions, the putative deuterium-labelled analogue, the authentic steroid and various mixtures of the two gave crystals of similar form.
Constancy ofthe HID ratios on re-crystallisation
Weighed mixtures of authentic steroid and the putative deuterium analogue were recrystallised from either acetone-iso-octane or methanol under conditions where only 20-40% was recovered as crystals. What appeared to be a single crystal was picked out and its melting point determined (see below). The material from the melting point tube was recovered and analysed by mass spectrometry and by the high-resolution HPLC systems described above. In the latter case, quantitation was by UV absorption or by RIA. The remaining crystals were pooled, ground and similarly analysed. The ratios of 'heavy' to 'light' steroid in each fraction were, within limits of about 5%, similar to the ratios weighed. Similar results were found in those cases where serial re-crystallisation was performed and also when the weighed ratios were varied within wide limits.
Melting points
In each case investigated, the putative deuterium-labelled analogue and the authentic steroid gave identical melting points when crystallised under similar conditions. Mixed melting points, where possible, were also the same. The melting points of single crystals from the previous experiments (see the section on constancy of the HID ratios on re-crystallisation above), shown to contain both components in varying ratios, did not differ from those of the authentic steroids.
Consistency
A large number of deuterium-labelled substances have. been prepared in this laboratory. The chromatographic isotope effects for similarly-labelled compounds are comparable, even predictable. The chromatographic isotope effect per substituted deuterium atom was approximately half that per substituted tritium atom at a similar position, determined using well characterised, commercially available material.
ISOTOPE DILUTION
Progesterone
The elution pattern of a single plasma extract is shown in Fig. 9 . The only cross-reacting material present is 5a-pregnan-3, 20-dione. It is possible to inject several samples rapidly after each other. wait until all the pregnanedione fractions have eluted and then assay subsequent fractions for progesterone. Results are shown in Fig. 10 . A similar strategy was followed for most subsequent isotope dilution experiments.
A series of plasma samples was analysed by Isotope dilution analysis 265 HPLC-isotope dilution using radioimmunoassay on each sample as the 'detector'. The ratio of H-to D-progesterone was, in this case, calculated using a standard curve in the immunoassay. The calculated concentrations of progesterone were compared with those of the reference RIA. The regression is shown in Fig. 11 . The regression lines comparing methods were also calculated using the 'non-parametric' method40-4X (see under the section on Materials and methods above). Fig. 12 shows the corresponding comparison of isotope dilution using enzyme immunoassay and the reference radioimmunoassay. Figure 8 shows the construction of a linear measure of antigen concentration in a RIA for unlabelled-and deuterium-labelled steroid. For HPLC-isotope dilution assays without the use of a standard curve, other linear transformations, e.g. logit-log, could be used. Isotope dilution assays on a number of plasma samples were carried out omitting the use of a standard curve in the RIA. Antibody-bound immunoassay tracer was corrected as explained in the Materials and methods section above. An estimate was made of the linear parameter for the base line. This was subtracted from all other values. The linear parameter values for anyone peak (H-or D-) were summed and the ratio HID was used as the estimate of isotope dilution from which the concentrations of unlabelled progesterone in the original samples were calculated. A comparison of these values with those of the reference RIA on the same samples is shown in Fig. 13 . Figure 14 shows the correlation between the results of HPLC-isotope dilution-RIA for androstenedione (using only the linear parameter, omitting the standard curve) and the 30 D '" c. Elution is from left to right. Each 2-min fraction was assayed by radioimmunoassay. Samples were injected at 0,33,66 and 99 min as shown at the left. The four peaks of immunoreactive 5a-pregnan--3,20-dione eluted during the next 120 min followed by the eight progesterone peaks which were used to calculate the results. 6d 60 40 ,.
Androstenedione and testosterone
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. , 2 i 00 2 4 6 ' 20 60 40 20 .. Regression of HPLC-ID-RIA results for androstenedione with those obtained using the reference radioimmunoassay on the same samples. The use of a standard curve was omitted as explained in the legend to Fig. 13 and in the text. y= -0·1 +0·97x.
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FIG. 13. Regression of HPLC-ID-RIA results for progesterone with those obtained using the reference radioimmunoassay on the same samples. Note the expanded scale within the dotted lines near the origin. In this case, the standard curve was ignored in the isotope dilution assays and the isotope-ratios calculated from the sums (integrated per peak) of the reciprocals of the corrected antibody-bound immunoassay tracer as explained in the text. y= -0·01 +0·993x.
reference-RIA on the same plasma samples. Figure 15 shows the corresponding comparison for plasma testosterone. Table 3 shows a comparison of testosterone values obtained using HPLC-isotope dilution-RIA with consensus and reference values for samples from two national external quality control schemes.
The usefulness of UV detection was explored using plasma testosterone as a model. 9·5 ng of testosterone-Dg,», 60 Ilg of cortisol and 30 Ilg of oestradiol were added to 3 mL of plasma. Equilibration, extraction and chromatography were the same as for the HPLC-isotope dilution method using RIA for quantitation. The identity of the testosterone peaks (H-and D-) was confirmed by RIA on fractions of the effluent from the detector. The UV trace is shown in Fig. 16 . The isotope ratio was calculated from the peak areas. The comparison of these isotope-dilution experiments with reference RIAs is shown in Fig. 17 . Values greater than 20 nM agreed well with expectations. Lower values were, in this example, overestimated. There are probably two explanations for this. Firstly, the response of the detector was not linear. Secondly, the amounts of endogenous testosterone in these samples is near the detec- deuterium-labelled ll-oxoprogesterone and ll~-hydroxyprogesteronehad been added are shown in Fig. 18 . In three men, the concentrations of these steroids were below the detection limit of the method as it was used then (0,5 nx). In three umbilical cord blood serum samples from normal male infants, small quantities of ll-oxoprogesterone (4·5, 3·0 and 2·8 nM) were measured but l1~-hydroxy progesterone concentrations were below the detection limit.
Discussion
Given the availability of JH-Iabelled compounds for use in immunoassay, it might be considered superfluous to consider the use of 2H-analogueS as internal standards. This is to some extent true. However, I have been concerned with presenting a convincing account of what could be a useful and general analytical method. To this end, I have chosen a number of readily-available models; it is not my purpose to present proposals for new routine methods for r,rogesterone, androstenedione etc. The use of H-labelled compounds as internal standards may offer advantages even when radioactive analogues are available. Procedural losses can be more easily and reliably estimated using 2H than JH in the presence of the large isotope effects found in really efficient separation methods. For instance, when radioactive analogues are used, many chromatography frac- . Elution curves of two plasma samples to which deuterium-labelled l l-ketoprogesterone and ll~ hydroxyprogesterone had been added. Elution is from left to right. Fractions were assayed for immunoactive material using an antiserum raised to a protein conjugate of 11a-hydroxyprogesterone hemisuccinate. Only the antibody-bound radioimmunoassay tracer is shown in the-ordinate. In the sample from a normal man (b, below), these steroids could not be demonstrated. The concentrations were below 0·5 nM. In the sample of cord-blood (a, above), an ll-ketoprogesterone concentration of 4·5 nM was measured.
tions will contain absolutely carrier-free material which is likely to behave differently from the endogenous analyte. Partial exchange of radioactive isotope during the assay results in substantial errors. Limited exchange does not affect the method proposed in this paper (massive exchange in any individual sample will be obvious immediately on inspection of the results). These are important considerations when the combination HPLC-ID-immunoassay is being considered as a reference method. The combination HPLC-ID-immunoassay could be considered for large scale application when used in combination with automated HPLC and automated immunoassay (EIA, RIA, chemiluminescence-linked immunoassay etc.) I envisage the isotope dilution method proposed in this paper also as a method for analytes which are otherwise difficult to assay. Examples of the latter are the assays for 11-oxoprogesterone and ll~-hydroxyprogesterone described in this paper where neither a specific antiserum nor a radioactive analogue of each steroid is available. When high-resolution microbore systems become more readily available, this form of isotope dilution may well be used for those analytes which are at present assayed by conventional HPLC. Examples are: catecholamines, plasma-and urine cortisol, plasma oestriol and many drugs. The example of testosterone assayed by HPLC-ID-UVabsorption described in this publication illustrates the potential of non-immunoassay detection methods. Values above 20 nM were estimated accurately. All analytes which are assayed using UV-absorption in the clinical laboratory occur in concentrations far greater than 20 nM. The results with low concentrations of testosterone illustrate the shortcomings of a non-selective detection system used near the limit of its sensitivity even when coupled with a very efficient purification. A number of commercial firms offer a large range of deuterated compounds. It should be clear to the reader that the constraints on the production of such compounds for HPLC-ID are far fewer than for GOMS applications. A large number of useable deuterium-analogues can be produced in gram quantities by any clinical laboratory.
HPLC-ID-IMMUNOASSAY AS A 'REFERENCE
METHOD'
This form of isotope dilution invites comparison with GC/MS methods which have been prop-osed as 'absolute-', 'definitive-' or merely 'reference-' methods. 14--18 'Absolute' in the analytical-chemical context is not the same as highly accurate. An absolute analytical method is one which avoids the use of standards. Examples of such methods in clinical chemistry are the gravimetric method for serum lipid, the gravimetric assay of cholesterol as the digitonide, the Kjeldahl method for blood sugar and the van Slyke method for plasma bicarbonate. Not all of these methods are renowned for their accuracy. All GOMS methods for large molecular weight compounds use a standard curve in addition to the isotopically-labelled internal standard. The results cannot be calculated on the basis of the observed ratio and the mass of the labelled analogue alone. Many factors are responsible for the deviation of the observed ratio from the real one. The most important of these are: isotope effects on the fragmentation pattern, lack of isotopic homogeneity of the tracer and the effect of 13C in the endogenous, unlabelled compound on the measurements when the mass increment of the tracer is relatively small (~3 atomic mass units). Isotope dilution using HPLC followed by radioimmunoassay (omitting the standard curve as described in the Introductory and Results sections) or by UVabsorption approaches the concept of an absolute method more closely than does GOMS.
In assessing analytical methods, the concepts of a priori and a posteriori criteria of accuracy are ,useful.
A posteriori criteria
The final arbiter of analytical accuracy of a new method is the experimental demonstration of a lack of interference. In the preceding summary of my experiments on HPLC-isotope-dilution assays, this has been demonstrated for progesterone, androstenedione and testosterone with a reasonable degree of probability. The experimental criteria of accuracy for the reference immunoassays are refered to in the Materials and methods section. The proposed method therefore satisfies the usual a posteriori criteria of accuracy. GOMS methods using dual-ion monitoring are, in general, highly accurate. However, many publications of these methods do not include objective criteria of accuracy in the sense that sources of error have been actively sought but not found. Reliance often seems to be placed on proof by declamation. Accuracy of these methods is not selfevident. All GOMS methods for steroids, prostaglandins and drugs use a chromatographic step to clean-up the sample prior to derivatisation and assay.V: S8 We have seen that even low-resolution chromatographic systems show isotope effects. Recoveries of the endogenous and labelled substances can therefore differ (see the section on Isotope effects as sources of analytical error below). Carbon isotope effects are also found so that the use of 13C-analogues does not exclude this source or error. Many chemical procedures introduce the possibility of exchange-out of deuterium. Immunochemical purificatiorr'" may introduce non-labelled metabolite in the samples. This is because an antiserum raised to a naturally occuring metabolite will always contain a very high concentration of that metabolite. These factors may lead to gross errors no matter how high the mass-resolution of the spectrometer and no matter how many fragments are monitored per analyte. Other unsuspected sources of error may be present under certain circumstances. An example is the so-called 'mass spectrometric re-cycling error'. so A priori criteria Without detracting in any way from the necessity for actively seeking sources of error in proposed reference methods, it is worthwhile to examine the theoretical basis of the accuracy of a proposed method. No method is absolutely accurate in the sense that error can never occur. There is a scale of accuracy from the hopeless to the excellent. The place of a particular assay method on this scale is determined by the probability of occurrence and the magnitude of error. Accuracy is therefore a stochastic concept. The accuracy of GC/MS methods (when a selected ion of the endogenous metabolite and of the labelled analogue are monitored) is determined by the probability that a chemical derivative of a potentially interfering substance will have the same mobility on gas chromatography and will give a fragment corresponding to either the metabolite itself or its labelled analogue. Multirle mass-spectrometric peaks due to natural 3C-substitution in potentially interfering substances increase this probability considerably in low mass-resolution detectors. Published methods often show mass spectrograms where two ions are continuously monitored. These often show small peaks in addition to the substance to be measured. The probability of similar peaks underlying the peaks attributable to the endogenous metabolite or its labelled analogue is not therefore negligible.
Isotope dilution anaLysis 271
There exists then the possibility of large specific interference by compounds present in low concentration or low specific interference by compounds present in high concentration. It should not be forgotten that the method is non-specific in the sense that an unexpected, totally unrelated compound, for instance a triterpene of plant origin present in some foods, drugs or cosmetics, may possess the same combination of chromatographic mobility and a particular fragment mass. The combined probability is undoubtedly low in most cases, particularly when the mass spectrometric resolution is better than 0·01 atomic mass unit. The ability of modern apparatus to produce a complete mass spectrum of a chromatographic peak reduces the chances of gross error still further.
The a priori accuracy of the isotope-dilution method using HPLC and immunoassay as described in this paper is determined by the probability that an unsuspected substance will have the same chromatographic mobility in the very high efficiency chromatography and react with the antiserum used. The occurrence of cross-reactions in immunoassays is well appreciated and understood.V Cross-reactions can be predicted quite accurately. For this reason, we can easily define the range of potentially interfering materials. The spectrum of substances which can interfere in an immunoassay is quite different from that of GOMS. Immunoassays rely on the molecular recognition of the shape and polarity of the antigen by the antibody. This means that closely-related chemical substances are likely to give crossreactions, whilst completely unrelated substances of similar molecular weight will give no interference at all. This has been verified adequately experimentally.
The probability that a particular substance will interfere in a GCIMS-assay is very low but this probability is the same for all substances regardless of their relatedness to the analyte. In the case of steroids, we can now be certain that no non-steroidal compounds will interfere with the actual antibody binding after chromatographic removal of the bulk of the serum lipids which can interfere non-specifically. Using the general conclusions summarised in a recent review.i" we can predict that only some 2000 steroids could give cross-reactions above the 0·001 % level in the reference immunoassay for testosterone. These compounds result from chemically-feasible combinations of any two of the following modifications to the basic testos-terone structure. These are: Sa-reduction (one possibility), the presence of an extra double bond (nine possibilities), the single double bond at a different position in the molecule (10 possibilities), reduction or oxidation at C-3 or C-17 (four possibilities, a/~), displacement of oxygen functions to a neighbouring carbon (three possibilities), an extra hydroxyl group (19 possibilities, a/~) and an extra ketone group (eight possibilities). Chemically-feasible combinations of any three modifications to the steroid will almost certainly result in crossreactions below 0·001 %. Epimers at carbons 8, 9, 10, 13 or 14, homoand nor-testosterones are known not to react. Cross-reactions below 0·001 % are unlikely to be relevant because of the limitations of steroid solubility in human serum. Of the 2000 candidate cross-reacting compounds, only some 200 are physiologically realistic in that they result from known physiological processes, e.g. ll~-hydroxylation, ketone reduction and reduction of the 4:5 double bond. We can state categorically that the great majority will have greatly differing chromatographic mobilities on HPLC. We cannot be so categorical about a very few of these potentially interfering compounds such as Saandrost-l-ene-I'tp-ol-Svone, androst-t-ene-Spol-D-one or 17a-testosterone. These can, however, be shown experimentally to differ from testosterone in chromatographic mobility.
The above arguments refer to the use of HPLC-ID-immunoassay methods under the most unfavourable circumstances imaginable. In practice, the fact that, for example, the testosterone reference immunoassays satisfies the most stringent criteria of accuracy, even without chromatography, indicates that none of the potentially interfering compounds is present in concentrations high enough to interfere. The same arguments hold for a large number of analytes.
The proposed HPLC-ID-immunoassay system used as a reference method allows us to investigate the chromatographic fractions further to confirm specificity, should the need be felt. For instance, aliquots of each fraction could be re-analysed using antiserum preparations of differing specificity. A chemical derivative could be made and the products rechromatographed to give a second estimate of the isotope ratio.
A priori probabilities as criteria of accuracy of either GC/MS of HPLC-ID-immunoassay are very difficult to quantitate or even compare because the spectra of potentially cross-reacting substances are completely different. However, I believe that the above arguments allow one to place as much trust in results obtained with an HPLC-ID-immunoassay using a well chosen antiserum as with GC/MS using two well chosen ions.
Having said this, we should bear in mind that the need for reference or definitive methods may be overstated. The accuracy of most simple routine assays is sufficient for clinical purposes, and shortcomings, should they arise, can usually be investigated using less sophisticated methods.
POTENTIAL APPLICATIONS IN IN VIVO
TRACER STUDIES
The great majority of determinations in clinical chemistry involve quantitative assays of various metabolites in biological fluids. Exceptionally, the 24 h excretion of a metabolite is measured. These assays are sufficient for the great majority of clinical requirements which seek to estimate deviations from a norm on an arbitrary and not necessarily linear scale (by which I mean that, for instance, plasma concentrations are seldom linear functions of production rates). In the case of endocrinology and toxicology, plasma concentrations are of interest in themselves because they represent the activity stimulating a target organ or producing a toxic effect.
In a few cases, direct measurement of production rates in vivo gives valuable diagnostic information. This is likely to be the case for eicosatetraenoic acid metabolites, catecholamines and cyclic nucleotides where the biological effect is exerted locally and breakdown is very rapid. The concentrations in peripheral venous blood (after passage through veins, lungs, arteries and a peripheral organ, usually a hand) cannot be expected to reflect local conditions. Other compounds are broken down through a variety of pathways which are subject to large unpredictable individual or temporal variation (examples are androgens and glucocorticoids). Measurement of production rates may well give clinically more useful results than estimates of the 24 h excretion of one or a few metabolites. These considerations ilre not restricted to hormones, hormone-like steroids and peptides but apply to a whole range of metabolites such as plasma proteins, lipoproteins, uric acid, adenine, porphyrins and vitamins, where subtle variations in the individual's capacity to regulate synthesis or excretion are thought to be involved in the aetiology of many diseases.
One method for the estimation of production rates is to infuse a radioactive compound so that a steady state is achieved when the injected labelled compound is in equilibrium with the endogenous material in the pool which is to be sampled. Either the compound itself or a metabolite is isolated and its specific activity measured. Using a simple isotope-dilution formula, the production rate is calculated." In view of objections to the injection of radioactive materials, alternative methods using 2H, 13C, 15N, 1HO etc. have been developed. After reaching a steady state, an excretory product is isolated. The ratio, labelled:unlabelled compound is measured by GClMS, monitoring two distinctive ions corresponding to the two isotopic forms. [62] [63] [64] It should be clear now to the reader that the chromatographic separation methods which form the subject of this publication might also be used to determine the ratio of isotopic forms in the estimation of production rates and metabolic clearances. The advantages of chromatographic separation are the great sensitivity when used in combination with immunoassay (which allows us to use the substance itself instead of a urinary metabolite), its comparative insensitivity to metabolically-induced deuterium exchange and its low cost.
An extension of this approach would be the use of compounds labelled with stable isotopes as metabolic tracers in humans. For example, an infusion of deuterium-labelled progesterone might be set up. Samples of blood, saliva or urine might then be assayed using high resolution chromatography combined with immunoassays for l l-desoxycorticosterone and progesterone, which will give double peaks: one attributable to the endogenous metabolite and the other to its deuterium-labelled analogue. The rate of 2l-hydroxylation by extraadrenal tissue could be calculated from the results.
Results of in vivo experiments obtained in this laboratory using chromatographic separation to estimate isotope ratios will be published shortly.
Isotope dilution employing physical separation of isotopically-labelled species can certainly be used for many investigations where a GC/MS capability is now considered necessary. It is interesting to note that the stimulus for developing GClMS with dual-ion-monitoring appears, at least in part, to have been the need to verify suspected chromatographic isotope effects. 65
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ISOTOPE EFFECTS AS SOURCES OF ANALYTICAL ERROR
As outlined in the Introductory section, isotopically-labelled analogues are used in many kinds of assay (e.g. some radioimmunoassays and GC/MS) as internal standards to correct for procedural losses. In the presence of a chromatographic isotope effect, a fraction may be taken for further analysis which contains all of the internal standard but less of the endogenous, unlabelled material. Improving chromatographic efficiency actually lowers analytical accuracy instead of increasing it. It should be noted that the analyses reported in this publication are free from this sort of error because no attempt was made to clean up the samples chromatographically before the estimation of the isotope ratios.
ISOTOPIC ENRICHMENT
An obvious application of chromatographic separation of isotopically-labelled compounds is the improvement of enrichment. It is clear that this method will be profitable only when the preparation is isotopically grossly heterogeneous. A glance through the catalogues of manufacturers of radiochemicals shows that only a small minority of labelled compounds fall into this category, presumably because considerable effort has been expended already in devising syntheses whereby tritium is incorporated using methods which do not involve exchange. The only application of chromatographic enrichment is likely to be for the small-scale production of special analogues through tritium-exchange where initial specific activities of more than 0·1 Curie per millimole are difficult to attain.
A potential extension of this method is the production of truly carrier-free 12C_ or 18F_ labelled radiopharmaceuticals. Present methods of synthesis give products with specific activities far below the theoretical maxima.
The use of semi-preparative HPLC to enrich deuterium-labelled compounds is described in this publication in the Materials and methods section. The product of enrichment of deuterium-labelled ll-oxoprogesterone gave demonstrably better results than did the non-enriched material.
OTHER METHODS FOR THE SEPARATION OF
ISOTOPICALLY-LABELLED COMPOUNDS
Some other potentially useful chromatographic methods have been mentioned earlier (see the section on isotope effects in chromatography above). These methods should allow the extension of this approach to analogues containing fewer deuterium atoms per molecule and, combined with computer resolution of overlapping peaks (see the Materials and methods section above), possibly to 13C-labelled compounds.
The approach described in this paper is general. It is not restricted to the chromatographic analysis of low molecular weight compounds. Otherseparation methodscould be used.
Electrophoresis can, in theory, separate isotopically-labelled species. The separation factors are equal to the ratios of the square roots of the respective molecular weights.
Density gradient centrifugation is capable of separating 'heavy' and 'light' forms of proteins. The separations resemble that of the classical Meselson-Stahl experiment using 15N-label1ed DNA. bb Such separations of 'light' and 'heavy' proteins have already found application in plant physiology where seeds were fed 'heavy' amino acids. 'Light' and 'heavy' forms of a particular protein were separated on a density gradient and measured. In this way, de novo synthesis during the experiment could be fol1owed without interference from existing protein of the same typeY The potential applications in human physiology are somewhat different. Proteins labelled with, for instance, 15N and 2H would be produced by biosynthesis from commercially-available aminoacids and injected. Serum or urine samples would be subjected to separation on a density gradient and analysed by, for example, immunoassay. Useful information concerning rates of synthesis and breakdown could be obtained. At present, such information is obtained using 1251-label1ed protein.P" 69 The approach using physical separation of the isotopically-label1ed form avoids the use of radioiodinated protein which may wel1 behave differently from native protein as well as exposing the patient or volunteer to unnecessary radiation exposure. the proposed procedure avoids one of the drawbacks of tritium-labelled peptide, namely that of recycling of the label.
The use of chromatographic, electrophoretic and ultracentrifuge methods for the separation of isotopically-labelled compounds in the study of human pathophysiology is being pursued in this laboratory.
